Literature DB >> 2042271

Duplex ultrasound findings in men with Peyronie's disease.

J A Lopez1, J P Jarow.   

Abstract

Peyronie's disease is a fibrotic process involving the penis, which presents with painful erections, penile chordee, and, less frequently, impotence. Duplex Doppler ultrasound is particularly well suited to the evaluation of these patients, since it can provide information about Peyronie's plaque and the penile vasculature noninvasively. Duplex ultrasound examinations were performed on 30 impotent and three potent men with Peyronie's disease. Presenting symptoms included painful erections in 30% and abnormal curvature in 93%. A plaque was palpable in 31 (94%) of the patients. Ultrasound evaluation revealed evidence of a plaque in only 13 (39%) patients. The majority of these plaques were visualized as hyperechoic areas with or without shadowing. Some isoechoic plaques were identified due to significant thickening of the dorsal tissues. Doppler analysis of cavernosal artery blood flow revealed evidence of arterial disease in eight (27%) of the impotent patients. Although ultrasonography was not as sensitive as palpation in identifying Peyronie's plaques, ultrasonography was better able to determine the depth of fibrosis extension into the corpora.

Entities:  

Mesh:

Year:  1991        PMID: 2042271     DOI: 10.1007/bf02924008

Source DB:  PubMed          Journal:  Urol Radiol        ISSN: 0171-1091


  3 in total

1.  Peyronie's disease. Investigation of staging, erectile failure and operative management.

Authors:  S Kümmerling; J Schubert
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

Review 2.  Peyronie's disease: a literature review on epidemiology, genetics, pathophysiology, diagnosis and work-up.

Authors:  Sultan Al-Thakafi; Naif Al-Hathal
Journal:  Transl Androl Urol       Date:  2016-06

3.  Ultrasound on Erect Penis Improves Plaque Identification in Patients With Peyronie's Disease.

Authors:  Yu Liu; Dequan Zheng; Xiaolin Liu; Xiaohong Shi; Shengchun Shu; Jinbing Li
Journal:  Front Pharmacol       Date:  2019-04-04       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.